Originaltext
Diese Übersetzung bewerten
Mit deinem Feedback können wir Google Übersetzer weiter verbessern
Home
Glenmark Pharmaceuticals Limited
Press Release Oct 20 2022
Business
Oct 20 2022
3 min read

Press Release Oct 20 2022

Glenmark Pharmaceuticals Limited has informed the Exchange about press release dated 20-Oct-2022 titled Glenmark becomes the First Company in India to launch Teneligliptin + Dapagliflozin Fixed Dose Combination, for Adults with Type 2 Diabetes, having Comorbidities.

View Attachment